Earnings Call · Q1 FY2022·2022-05-12

Q1 22EPS +28.57%·Rev n/aQ4 21EPS 0.00%·Rev n/aQ3 21EPS -2.86%·Rev n/aQ2 21EPS -10.20%·Rev n/a⚠ consensus missing

Dare Bioscience, Inc. DARE

Sabrina Martucci Johnson — Chief Executive Officer (CEO)

John Fair — Chief Medical Officer (CMO)

Lisa Walters-Hoffert — Chief Financial Officer (CFO)

+9.6%1d on move date+9.7% vs SPY3d+20.2%5d+12.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DARE calls or request research access.

More DARE calls Browse calls Request research access